Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284930 · ClinicalTrials.gov registry record · Phase 4
Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT04284930 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 21 participants.
The verdict
NCT04284930, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
Effective post surgical pain control in patients undergoing unilateral deep inferior epigastric perforator (DIEP) free flap reconstruction.
Interventions
- DRUG 0.25% Bupivacaine
- DRUG Depobupivacaine
- DRUG OnQ pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04284930
The ClinicalTrials.gov registry entry for NCT04284930 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.25% Bupivacaine is the first listed.
NCT04284930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04284930 about?
NCT04284930 is a clinical study titled "Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management". Effective post surgical pain control in patients undergoing unilateral deep inferior epigastric perforator (DIEP) free flap reconstruction.
What is the current status of trial NCT04284930?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2016-02. Estimated completion is 2017-11.
What interventions are being tested in trial NCT04284930?
The interventions under investigation include: 0.25% Bupivacaine (DRUG), Depobupivacaine (DRUG), OnQ pump (DRUG).
Who is sponsoring clinical trial NCT04284930?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.